These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10921397)

  • 1. Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C.
    Omata M; Shiratori Y
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E134-40. PubMed ID: 10921397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histological findings in the liver in patients with chronic hepatitis C].
    Takase K; Shiraki K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):434-8. PubMed ID: 15359838
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.
    Almasio PL; Venezia G; Craxì A
    Panminerva Med; 2003 Sep; 45(3):175-82. PubMed ID: 14618115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Oct; 79(10):1485-90. PubMed ID: 17705189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment.
    Chavalitdhamrong D; Tanwandee T
    World J Gastroenterol; 2006 Sep; 12(34):5532-5. PubMed ID: 17006994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic hepatitis C.
    Imazeki F; Yokosuka O; Fukai K; Kawai S; Kanda T; Kojima H; Saisho H
    Liver Int; 2005 Aug; 25(4):772-8. PubMed ID: 15998428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S; Kubo S; Shiomi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?
    Shiratori Y; Omata M
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E141-51. PubMed ID: 10921398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.
    Omata M; Yoshida H; Shiratori Y
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S141-3. PubMed ID: 16234063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents.
    Huang CM; Hu TH; Chang KC; Tseng PL; Lu SN; Chen CH; Wang JH; Lee CM; Tsai MC; Lin MT; Yen YH; Hung CH; Cho CL; Wu CK
    Medicine (Baltimore); 2017 Nov; 96(46):e8696. PubMed ID: 29145306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiviral therapy in the prevention of hepatocellular carcinoma.
    Franco J; Saeian K
    J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S191-6. PubMed ID: 12354836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials.
    Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ge YS
    Int J Cancer; 2011 Sep; 129(5):1254-64. PubMed ID: 21710498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic hepatitis C in hemodialysis patients].
    Tanaka H; Ueda H; Ichinose M; Miyano M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):645-8. PubMed ID: 15359877
    [No Abstract]   [Full Text] [Related]  

  • 15. Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.
    Shirabe K; Sugimachi K; Harada N; Kayashima H; Maeda T; Tsujita E; Minagawa R; Kajiyama K; Yoshiya S; Maehara Y
    Anticancer Res; 2015 Dec; 35(12):6963-9. PubMed ID: 26637923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: flaws in the cure, or a clue to the flaws?
    Farrell GC
    J Gastroenterol Hepatol; 1999 Sep; 14(9):833-7. PubMed ID: 10535462
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
    J Gastroenterol Hepatol; 2017 Mar; 32(3):687-694. PubMed ID: 27577675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C.
    Takata K; Ishii F; Uchida Y; Fukuda H; Yamauchi R; Umeda K; Tsuchiya N; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Intern Med; 2020 Aug; 59(15):1855-1860. PubMed ID: 32350199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma occurring after 11 year-long sustained viral response to interferon therapy for chronic hepatitis C].
    Suganami F; Tomiyama Y; Ohmoto K; Kawase T; Yoshioka N; Shibata N; Yoshida K; Kuboki M; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jun; 104(6):809-14. PubMed ID: 17548948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of interferon-based therapy for chronic hepatitis C.
    Yu ML; Huang CF; Dai CY; Huang JF; Chuang WL
    Oncology; 2007; 72 Suppl 1():16-23. PubMed ID: 18087178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.